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OBJECTIVE — To investigate the relationship between health-related quality of life
(HRQOL) and mortality in type 2 diabetes.
RESEARCH DESIGN AND METHODS— In 1998, 1,143 primary care patients with
type 2 diabetes participated in the Zwolle Outpatient Diabetes project Integrating Available Care
(ZODIAC) study. At baseline, HRQOL was assessed with the RAND-36 and, after almost 6 years,
life status was retrieved. Cox proportional hazards modeling was used to investigate the associ-
ation between HRQOL (continuous data) and mortality with adjustment for selected confound-
ers (smoking, age, sex, diabetes duration, A1C, renal function, BMI, blood pressure, HDL
cholesterol, and macrovascular complications).
RESULTS— The Physical Component Summary of the RAND-36 was inversely associated
with mortality (hazard ratio [HR] 0.979 [95% CI 0.966–0.992]), as were two separate RAND-36
dimensions.
CONCLUSIONS— This study found that HRQOL is an independent marker of mortality
and emphasizes the importance of looking beyond clinical parameters in patients with type 2
diabetes.
Diabetes Care 31:932–933, 2008
Among others, hypertension anddyslipidemia are well-known clini-cal risk factors in type 2 diabetes
and should be treated accordingly (1).
However, studies in nondiabetic popula-
tions have also found that factors like
worse health-related quality of life
(HRQOL) are associated with higher mor-
tality (2–4). If this holds true for patients
with type 2 diabetes, clinicians might
have to give more attention to HRQOL
and perhaps assess HRQOL routinely in
these patients. This study is, to our
knowledge, the first one investigating the
relationship between HRQOL and mor-
tality in type 2 diabetes.
RESEARCH DESIGN AND
METHODS— In 1998, 1,143 pri-
mary care patients with type 2 diabetes
participated in the Zwolle Outpatient Di-
abetes project Integrating Available Care
(ZODIAC) study (5). Patients with seri-
ous comorbidity or impaired cognitive
abilities were excluded (n 57). Baseline
data involved a full medical history in-
cluding macrovascular complications, di-
abetes duration, BMI, and tobacco
consumption. Laboratory and physical
assessment data were collected and in-
cluded A1C, nonfasting lipid profile, se-
rum creatinine, albuminuria, blood
pressure, weight, and height. This study
was approved by the local medical ethics
committee.
HRQOL was measured with the
RAND-36 (6). The RAND-36 contains
nine health dimensions. To interpret the
overall direction of the HRQOL effects,
two summary measures can be calculated:
the physical (PCS) and mental (MCS)
component summary. Scores range from
0 –100; higher scores indicate better
HRQOL.
Life status in 2004 and cause of death
were retrieved from records maintained
by the hospital and general practitioners.
Ten baseline variables were selected for
their possible confounding effects in the
relationship between HRQOL and mor-
tality, i.e., smoking (yes or no), age, sex,
diabetes duration, A1C, renal function
(estimated with Cockcroft-Gault), BMI,
blood pressure, HDL cholesterol, and
macrovascular complications (yes or no).
Cox proportional hazard modeling
was used to investigate the association be-
tween HRQOL (continuous data) and
mortality with adjustment of selected
confounders. For Kaplan Meier curves,
HRQOL scores were dichotomized.
RESULTS— The study population in-
cluded 653 women (57%). Mean  SD
age at baseline was 68.2 11.5 years with
median diabetes duration 6 years (inter-
quartile range 3–11). Median follow-up
time was 5.8 years. At follow-up, 335 pa-
tients had died, 101 from cardiovascular
causes. Date of death was known in 329
(98%) patients.
Data on HRQOL were available from
1,000 (87%) patients and complete for
857 (75%) patients. Completeness of data
was inversely associated with mortality
(HR 0.355 [95% CI 0.272–0.462] for one
to eight missing scales; 0.549 [0.382–
0.788] for all nine missing scales com-
pared with complete data).
The PCS score was inversely associ-
ated with mortality (HR 0.979 [95% CI
0.966–0.992]). A decrease of 1 point on
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the PCS score led to an increase of the
hazard of mortality of 2.1%. A total of 145
(32.4%) of 448 patients with PCS scores
below the median died vs. 69 of 449
(15.4%) with PCS scores above the me-
dian (a 2.1 ratio) (Fig. 1). The MCS score
was not associated with mortality (1.008
[0.994–1.022]).
For separate RAND-36 dimensions,
significant relationships were found for
“physical functioning” (HR 0.989 [95%
CI 0.982– 0.996]) and “general health
perception” (0.982 [0.971–0.994]).
For cardiovascular mortality, results
remained significant for physical func-
tioning (HR 0.987 [95%CI 0.977–
0.996]) . HRs for genera l hea l th
perception and PCS were 0.967 [95% CI
0.967–1.000] and 0.982 (0.964–1.001),
respectively.
CONCLUSIONS— Worse HRQOL
is associated with higher overall mortality
in patients with type 2 diabetes in 6 year
follow-up after taking potential con-
founders into account. Patients with low
versus high HRQOL (PCS score) have a
2.1-fold increased mortality risk. Two
separate RAND-36 dimensions, physical
functioning and general health percep-
tion, were related to mortality. The former
has questions about ability to perform
physical activities, the latter questions
about patients’ opinion about their health
in general. Physical functioning was also
associated with cardiovascular mortality.
Limitations of this study were that
25% of patients did not fill in or complete
the questionnaire. However, this was
strongly related to mortality and has
therefore probably led to an underestima-
tion of the effects of HRQOL on mortality
(7). Of course, confounders other than
the 10 selected in this study could influ-
ence the prediction of mortality from
HRQOL, e.g., depression, which is more
prevalent in type 2 diabetes, is related to
worse HRQOL and higher mortality (8).
Furthermore, it is important to emphasize
that an association between HRQOL and
mortality does not establish causality.
Nevertheless, this study emphasizes
that in patients with type 2 diabetes it is
important to look beyond clinical param-
eters. Good HRQOL is an important goal
of health care in itself, yet demonstrating
that HRQOL is an independent marker of
mortality in type 2 diabetes provides an
added incentive for health care providers
to assess HRQOL routinely in diabetes
care, allowing any underlying unmet
needs to be identified and addressed
when possible. Further research is needed
to examine if the association reflects spe-
cific modifiable risks rather than overall
disease burden.
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Figure 1—Kaplan-Meier curve PCS.
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